Estrogen reversed the inhibitory effect of heteronemin against activation of ERK1/2 and STAT3 (Figure 4) in MCF-7 cancer cells and activation of PKC and STAT3 in MDA-MB-231 cancer cells (Figure 4) but diminished ERK1/2 in MDA-MB-231 cancer cells. Here, PRRT2 is linked to cancer.